AVIGI Therapeutics: Funding, Investors & Team (Sep 2026)
AVIGI Therapeutics is leading the way in creating new drugs through a rational approach that combines advanced chemistry and biotechnology to harness human capabilities.
AVIGI Therapeutics has raised $380k across 1 funding round on record, the most recent a Pre-Seed of $380k announced in Apr 2025.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
AVIGI Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2025.
AVIGI Therapeutics Funding Rounds
AVIGI Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
AVIGI Therapeutics Funding Compared to Other Health Care Startups
AVIGI Therapeutics' latest round of $380k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AVIGI Therapeutics in Health Care and Leiden
Companies Similar to AVIGI Therapeutics
The most cutting-edge polymer-based platform of restorative cardiovascular devices was created by Xeltis.…
Vitestro revolutionizes the way patients are cared for by introducing independent blood-drawing technology.
ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and…
Speaklee is a company that utilizes AI technology to create a speech assistant tool for children who have…
CardiacBooster is a company in the medical field that creates percutaneous devices to assist the left…
Plasmacure offers a patented cold plasma solution designed to heal chronic wounds. They provide services in…
Hy2Care® is a company that originated from the MIRA Institute at the University Twente in the Netherlands, a…
Platos Health is a technology startup dedicated to increasing access to preventive healthcare. Our current…
Sirius medical helps in improving healthcare for cancer patients by developing medical devices that helps in…
PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health…
Vico Therapeutics specializes in creating RNA-modulating treatments for rare neurological conditions. The…
AVIGI Therapeutics Funding FAQs
What does AVIGI Therapeutics do?
AVIGI Therapeutics is leading the way in creating new drugs through a rational approach that combines advanced chemistry and biotechnology to harness human capabilities.
How much funding has AVIGI Therapeutics raised?
AVIGI Therapeutics has raised $380k across 1 round on record. The most recent is a Pre-Seed of $380k announced in Apr 2025.
When did AVIGI Therapeutics last raise funding?
AVIGI Therapeutics' most recent funding round on record is a Pre-Seed of $380k, announced in Apr 2025.
Who founded AVIGI Therapeutics?
FundedIQ lists Vincent Lit (Founder) at AVIGI Therapeutics.
Where is AVIGI Therapeutics headquartered?
AVIGI Therapeutics is based in Leiden, Zuid-Holland, Netherlands.
How many employees does AVIGI Therapeutics have?
AVIGI Therapeutics is in the 1-10 employee band.
How does AVIGI Therapeutics' funding compare to other Health Care startups?
AVIGI Therapeutics' latest round of $380k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's AVIGI Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AVIGI Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.